Ensemble Discovery, Roche Team on Molecular Dx for Cancer Drugs | GenomeWeb
NEW YORK (GenomeWeb News) - Ensemble Discovery said today it has struck a collaboration with Roche to develop a test that may be used to analyze combinations of specific receptors that may be used to help select cancer patients that are most likely to respond to particular therapies.
 
Under the agreement, the companies will use Ensemble’s DNA Programmed Chemistry technology to study combinations of epidermal growth factor receptors that are found in some cancer tissues.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.